AGP Picks
View all

Healthy Living Maldives: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Maldives.

Press releases published on July 9, 2026

Daré Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event
Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of  QRX003 in Peeling Skin Syndrome
Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate
TOMI Reports 124% Increase in Preliminary Second Quarter Revenue; Preliminary Six Months Revenue Combined with Open Orders Surpass Full Year 2025 Revenue
Stereotaxis Completes Acquisition of Robocath
Alignment Healthcare to Announce Second Quarter 2026 Financial Results and Host Conference Call Thursday, July 30, 2026
Sam’s Club® and Weight Watchers® Collaborate to Expand Access to Affordable, Holistic Wellness Experiences for Members
UREVO Wins Red Dot Award 2026 for AI-Powered Wireless Recovery Boots, Recognized for Real-Time, AI-Adaptive Recovery
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
Tris Pharma Launches Adneuris Therapeutics to Advance a New Era in Pain Medicine
Fangzhou Named to KPMG China Healthcare 50 for AI-Powered Chronic Disease Care
Dysport® est la première toxine botulinique à obtenir des résultats préliminaires positifs de phase III, à la fois dans la migraine épisodique et dans la migraine chronique.
Dysport® is the first botulinum toxin to achieve positive topline Phase III results in both episodic and chronic migraine.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthy Living Maldives

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.